Showing results (451-460 of 668) with videos related to
Sort By:
Pageof 67
Hemasphere|April 17, 2025
Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP RegistryInés Gómez-Seguí, Joan Cid, Miquel Lozano, et al.Hemasphere|April 9, 2025
NGS-MRD negativity in post-HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse riskKrystof Seferna, Michael Svaton, Andrea Rennerova, et al.Hemasphere|April 14, 2025
Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Iman Abou Dalle, et al.Hemasphere|March 18, 2025
Loss of CYLD promotes splenic marginal zone lymphomaAthanasios Pseftogas, Jessica Bordini, Silvia Heltai, et al.Hemasphere|March 24, 2025
Low-risk MDS-A spotlight on precision medicine for SF3B1-mutated patientsShoshana Burke, Onima Chowdhury, Kevin Rouault-PierreHemasphere|March 26, 2025
Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotypeFrancesco Rodeghiero, Lisanna Ghiotto, Luca Pontalto, et al.Hemasphere|June 5, 2024
Human leukocyte antigen (HLA) class I expression on Hodgkin-Reed-Sternberg cells is an EBV-independent major determinant of microenvironment composition in classic Hodgkin lymphomaBerit Müller-Meinhard, Nicole Seifert, Johanna Grund, et al.Hemasphere|November 27, 2025
Sequencing BCMA- and GPRC5D-targeting immunotherapies in multiple myeloma: Practical guidance from the European Myeloma NetworkNiels W C J van de Donk, Philippe Moreau, Jesus F San-Miguel, et al.Hemasphere|December 31, 2025
TLX1 translocation variants and enhancer hijacking influence clinical outcome in T-cell acute lymphoblastic leukemiaEstelle Balducci, Thomas Steimlé, Agata Cieslak, et al.Pageof 67